ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July
